A Double-blind, Parallel Group, Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep

PHASE2CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Nonrestorative Sleep
Interventions
DRUG

PD 0200390

oral 15 mg daily dose, 3 capsules per dose during a six week treatment period.

DRUG

PD 0200390

oral 25 mg daily dose, 3 capsules per dose during a six week treatment period.

DRUG

PD 0200390

oral 35 mg daily dose, 3 capsules per dose during a six week treatment period.

DRUG

PD 0200390

oral 5 mg daily dose, 3 capsules per dose during a six week treatment period.

DRUG

PD 0200390

oral 50 mg daily dose, 3 capsules per dose during a six week treatment period.

DRUG

Placebo

oral placebo daily dose, 3 capsules per dose during a six week treatment period.

Trial Locations (59)

14224

Pfizer Investigational Site, West Seneca

15401

Pfizer Investigational Site, Uniontown

18411

Pfizer Investigational Site, Clarks Summit

20815

Pfizer Investigational Site, Chevy Chase

27103

Pfizer Investigational Site, Winston-Salem

27511

Pfizer Investigational Site, Cary

27612

Pfizer Investigational Site, Raleigh

28144

Pfizer Investigational Site, Salisbury

29201

Pfizer Investigational Site, Columbia

30328

Pfizer Investigational Site, Atlanta

30342

Pfizer Investigational Site, Atlanta

30501

Pfizer Investigational Site, Gainesville

32720

Pfizer Investigational Site, DeLand

32763

Pfizer Investigational Site, Orange City

32806

Pfizer Investigational Site, Orlando

33026

Pfizer Investigational Site, Pembroke Pines

33143

Pfizer Investigational Site, Miami

Pfizer Investigational Site, South Miami

34110

Pfizer Investigational Site, Naples

40504

Pfizer Investigational Site, Lexington

40513

Pfizer Investigational Site, Lexington

41017

Pfizer Investigational Site, Crestview Hills

45227

Pfizer Investigational Site, Cincinnati

46260

Pfizer Investigational Site, Indianapolis

60634

Pfizer Investigational Site, Chicago

63017

Pfizer Investigational Site, Chesterfield

63108

Pfizer Investigational Site, St Louis

66212

Pfizer Investigational Site, Overland Park

70809

Pfizer Investigational Site, Baton Rouge

72205

Pfizer Investigational Site, Little Rock

73112

Pfizer Investigational Site, Oklahoma City

75039

Pfizer Investigational Site, Irving

75230

Pfizer Investigational Site, Dallas

78756

Pfizer Investigational Site, Austin

80033

Pfizer Investigational Site, Wheat Ridge

85306

Pfizer Investigational Site, Glendale

Pfizer Investigational Site, Phoenix

85712

Pfizer Investigational Site, Tucson

89104

Pfizer Investigational Site, Las Vegas

89146

Pfizer Investigational Site, Las Vegas

90048

Pfizer Investigational Site, Los Angeles

91106

Pfizer Investigational Site, Pasadena

92103

Pfizer Investigational Site, San Diego

92780

Pfizer Investigational Site, Tustin

94105

Pfizer Investigational Site, San Francisco

06473

Pfizer Investigational Site, North Haven

06492

Pfizer Investigational Site, Wallingford

02135

Pfizer Investigational Site, Brighton

02747

Pfizer Investigational Site, North Dartmouth

27607-6520

Pfizer Investigational Site, Raleigh

02886

Pfizer Investigational Site, Warwick

02893

Pfizer Investigational Site, West Warwick

V1Y 3G8

Pfizer Investigational Site, Kelowna

V1Y 4R9

Pfizer Investigational Site, Kelowna

M9W 6V1

Pfizer Investigational Site, Etobicoke

N2G 1G1

Pfizer Investigational Site, Kitchener

P2A 3A4

Pfizer Investigational Site, Parry Sound

M4P 1P2

Pfizer Investigational Site, Toronto

M6J 3S3

Pfizer Investigational Site, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY